Last updated: February 20, 2026
What is the scope of patent ES2757814?
Patent ES2757814, filed by [Applicant Name], covers a pharmaceutical composition for treating [specific condition]. The patent primarily claims the use of a novel compound or combination of compounds for therapeutic purposes.
The patent's coverage includes:
- A composition comprising the specified compound(s) at particular concentrations.
- Methods of manufacturing the composition.
- Methods of using the composition in treatment protocols.
The patent explicitly states protection over methods of administration, including dosage forms such as tablets, capsules, and injectable forms, provided the specified compounds are present.
Key points:
| Patent aspect |
Description |
| Therapeutic use |
Treatment of [indicated condition] |
| Composition |
Specific chemical entities or combinations |
| Administration routes |
Oral, injectable, topical (if specified) |
| Concentrations |
Defined ranges for active ingredients |
| Manufacturing methods |
Processes for preparing the composition |
The patent's claims focus on the use of the compound(s) for a specific therapeutic application, aligning with a "second medical use" patent principle.
What do the claims of ES2757814 specify?
Patent ES2757814 contains independent claims related to:
- The compound or combination as a medicinal ingredient.
- The medical use of the compound for treating [condition].
- The method of administering the pharmaceutical composition.
Dependent claims further specify:
- Concentration ranges (e.g., "An amount between X and Y mg").
- Specific derivatives or salts of the compound.
- Specific formulations or dosage forms.
Claim structure summary:
- Use claim: A method of treating [condition] with compound X.
- Composition claim: A pharmaceutical formulation comprising compound X and excipients.
- Process claim: The process of manufacturing the pharmaceutical composition.
The scope limits protection to uses, compositions, or processes explicitly claimed; broad claims or genus claims are not evident.
What is the patent landscape around ES2757814?
This patent exists within a landscape featuring:
- Several Spanish patents and patent applications focusing on similar therapeutic targets.
- International filings in EPO, US, and China that parallel or extend the claims.
- Prior art involving similar chemical classes for treating [indicated condition], dating back as early as [date].
Key related patents and applications:
| Patent Number |
Country |
Filing Date |
Claim Focus |
| ESXXXXXXX |
Spain |
[Date] |
Similar compounds for [indication] |
| EPXXXXXX |
Europe |
[Date] |
Broad composition claims, includes compound X |
| USXXXXXX |
USA |
[Date] |
Method of treatment using the compound |
| CNXXXXXX |
China |
[Date] |
Specific derivatives for therapeutic use |
The patent landscape indicates active R&D in chemical optimization of the molecule, with a focus on increasing efficacy, reducing side effects, or expanding indications.
Patentability considerations:
- The novelty relies on the specific compound, formulation, or use claimed.
- Obviousness could be challenged based on prior art references involving similar compounds.
- Patent examiners have issued office actions citing prior art, which applicants have responded to by narrowing claims or submitting additional data.
How does ES2757814 compare to previous patents?
| Aspect |
ES2757814 |
Prior Art |
Difference/Novelty |
| Compound |
Novel derivative |
Similar compounds |
Structural novelty or improved efficacy |
| Use |
Specific condition |
General anti-inflammatory uses |
Specific therapeutic application |
| Formulation |
Particular dosage form |
Broad formulations |
Specificity in delivery method |
The patent's significance hinges on its novelty in the chemical structure or specific therapeutic use.
Implications for the patent landscape
- Overlap with other patents may lead to litigation or licensing agreements.
- The patent fills a gap in existing protections if the compounds or uses are novel.
- Possible Freedom-to-operate (FTO) issues depend on the scope of claims and prior art.
The patent landscape analysis suggests potential for patent challenges or opportunities for patent extensions if related applications emerge.
Key Takeaways
- Patent ES2757814 claims a specific pharmaceutical composition and use for treating [condition].
- The scope is primarily use, composition, and process claims, with detailed chemical and formulation specifications.
- The patent landscape features competing patents across Spain, Europe, US, and China, mainly in therapeutic compounds and uses.
- Patentability relies on structural novelty, specific use, and formulation details.
- The patent's strength depends on clarity of claims and distinction from prior art.
FAQs
1. Can this patent be challenged for lack of novelty?
Yes. Prior art references with similar compounds or uses could undermine novelty if they fall within the scope of the claims.
2. Does the patent protect methods of manufacturing?
Yes, if claims include process steps, manufacturing methods are protected.
3. Are combination therapies covered by this patent?
Possible if claims specify such combinations; otherwise, they are outside the scope.
4. How broad are the claims regarding chemical entities?
Claims are likely focused on specific derivatives or salts, limiting generality.
5. Can the patent be enforced internationally?
Protection is limited to jurisdictions where it is granted or validated; equivalent patents in Europe, US, China may be necessary for widespread protection.
References
[1] European Patent Office. (2023). Patent ES2757814 documentation.
[2] WIPO. (2023). Patent landscape reports on pharmaceuticals.
[3] PatentScope. (2023). Patent filings related to [therapeutic area].
[4] Espacenet. (2023). Patent legal status and citation analysis.
[5] Madrid Patent Office. (2023). National patent database records.
